Anticancer agent-364
Anticancer agent-364 is a phenylalanine-derived hydrazone heterocyclic compound that exhibits selective cytotoxicity against NSCLC lung cancer cells. Anticancer agent-364 inhibits VEGF-A, VEGFR-1, and VEGFR-2, increases caspase-3/7, caspase-8, and caspase-9 activity, and induces apoptosis. Anticancer agent-364 can be used for research on non-small cell lung cancer.
For research use only. We do not sell to patients.
- Formula: C22H16BrCl2N3O2
- Molecular Weight:505.19
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
VEGFR1 |
VEGFR2 |
Caspase-3 |
Caspase-7 |
Caspase-8 |
Caspase-9 |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | IC50 |
15.60 μM
|
Cytotoxicity against human non-small cell lung cancer A549 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay.
Cytotoxicity against human non-small cell lung cancer A549 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay.
|
42561562 |
| BEAS-2B | IC50 |
1200.00 μM
|
Cytotoxicity against human healthy lung epithelial BEAS-2B cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay.
Cytotoxicity against human healthy lung epithelial BEAS-2B cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay.
|
42561562 |
| PC-9 | IC50 |
22.49 μM
|
Cytotoxicity against human non-small cell lung cancer PC9 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay.
Cytotoxicity against human non-small cell lung cancer PC9 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay.
|
42561562 |
In Vitro
Anticancer agent-364 (compound 9d) (15.625-1000 μM; 24-72 h) exhibits IC50 = 15.60 μM against A549 cells, IC50 = 22.49 μM against PC9 cells, and IC50 = 1200.00 μM against BEAS-2B normal lung epithelial cells; the selectivity index SI = 76.92 for A549 and SI = 53.36 for PC9[1].
Anticancer agent-364 (IC20-IC50 values; 24 h) selectively induces apoptosis in A549 lung cancer cells, but does not induce apoptosis in healthy BEAS-2B cells[1].
Anticancer agent-364 (7.5-60 μM; 24 h) significantly reduces intracellular VEGF-A, VEGFR-1, and VEGFR-2 protein levels in A549 cells at intermediate concentrations, but has no significant effect on healthy BEAS-2B cells[1].
Anticancer agent-364 significantly activates caspase-3/7, -8, and -9 in A549 lung cancer cells at concentrations of 7.5 and 10 μM, indicating that it triggers both intrinsic and extrinsic apoptotic pathways[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:A549, BEAS-2B
-
Concentration:7.5, 10, 15 μM (A549)
15, 30, 60 μM (BEAS-2B) -
Incubation Time:24 h
-
Result:Reduced intracellular VEGF-A, VEGFR-1, and VEGFR-2 protein levels in A549 cells at intermediate concentrations, but has no significant effect on healthy BEAS-2B cells.
Chemical Information
-
Molecular Weight 505.19
-
Formula C22H16BrCl2N3O2
-
SMILES
BrC1=CC=CC(/C=N/NC(C(C2=CC=CC=C2)NC(C3=C(Cl)C=C(Cl)C=C3)=O)=O)=C1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Detection of Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Mammalian live/dead viability and cytotoxicity staining
Live/dead viability and cytotoxicity staining assays are based on the simultaneous detection of intracellular esterase activity in metabolically active (viable) cells and membrane integrity loss in non-viable cells. In commonly used dual-staining approaches, membrane-permeant fluorogenic substrates are converted by intracellular esterases into fluorescent products in live cells, while impermeant DNA-binding dyes selectively enter cells with compromised plasma membranes and label nucleic acids in dead or dying cells, enabling discrimination between viable and non-viable populations by fluorescence microscopy or flow cytometry.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)